Manufacturing News of Note—Dr. Reddy's to have CDMOs produce some of its drugs in China

stocks
(Pixabay)

> Teva Pharmaceutical's plant in in Kfar Saba, Israel, has been approved to produce its new migraine treatment Ajovy. Story

> Dr. Reddy's is using contractors in China for production of some of its products. Story

> CDMO WuXi STA will handle development and production of cancer drugs for Chinese biotech Impact Therapeutics. Release

Free Amazon Webinar

Performing end to end real-world evidence generation in the cloud with traceability and transparency- a Sanofi journey

In this webinar you will hear about Sanofi’s journey and experience in building an industrialized big data & analytics platform in the cloud that handles billions of rows of RWD data with complete data traceability, security, and supports both traditional and advanced analytics for day to day evidence generation (RWE).

> The European Medicines Agency has cited Indian antibiotic producer Acharya Chemicals for a variety of GMP violations. Filing 

Suggested Articles

Nearly four decades after it was approved, the FDA has ordered that heartburn drug Zantac and its generics be removed from the market.

Pfizer's 1.1-million-square-foot sterile injectables plant in Visakhapatnam has been criticized by the FDA for poor quality testing.

Amidst a gung-ho shift to oncology, Daiichi is also fleshing out its gene therapy capacity with a $200 million licensing deal with Ultragenyx.